Brussels, Belgium, 16 February 2022 – From 1 to 4 February 2022, the EAHAD 2022 Virtual Congress took place. More than 2300 delegates joined and interacted online for our second virtual Congress. Due to ongoing Covid-19 uncertainty, our 15th Annual Congress remained a fully virtual event under the direction of the Congress Organising Committee, Prof. Flora Peyvandi, Dr Robert Klamroth, and Prof. Michael Makris. Thanks to the diverse, high quality sessions and presentations, EAHAD 2022 was the virtual place-to-be for the latest in the field of haemophilia and allied disorders.
The meeting opened on Tuesday 1 with the Allied Health Professionals Day. Streams dedicated to and tailor-made for physiotherapists, nurses and psychosocial professionals were shared with the European and international AHP community. For the first time ever, Tuesday hosted a bonus satellite symposium on Gene Therapy, that was extremely well received and surely will spark discussions about this novel haemophilia treatment option.
From 2-4 February, the main scientific programme took place. Wednesday 2 started with the Multidisciplinary Haemophilia Educational Session, which focused on the crucial topic of the MTD team’s response in times of disaster/crisis. Different presentations followed, with some highlights being on the immunogenicity of Factor VIII, as well as on thrombosis and novel haemophilia therapies. The day closed with the first of three recap sessions, where Robert Klamroth summarised the content of the day and gave his perspective on the issues explored during the eclectic presentations.
Thursday 3 offered attendees the chance to experience a highly anticipated session on Gene Therapy, as well as very interesting presentations on the European accreditation of haemophilia and gene therapy centres, and the European Haemophilia Safety Surveillance project. We ended with the second recap session, chaired by EAHAD President Flora Peyvandi.
Friday 4 hosted two EAHAD Congress staples: the always exciting SLAM session and the Arosenius Lecture. Nevertheless, the crown jewel of EAHAD 2022 was the Latest Clinical Trial Results session.
With six not-to-be-missed presentations, the session offered a deep dive into key issues that can potentially transform the future haemophilia and allied disorders landscape.
Our second virtual Congress ended with the final recap session, chaired by Michael Makris. Prof. Makris was joined by fellow Organising Committee members Flora Peyvandi and Robert Klamroth for the closing remarks.
The EAHAD 2022 Virtual Congress and its sessions and presentations were met with universal acclaim online. We would like to thank everyone that joined and supported us in our second online scientific journey. Don’t forget that all content will remain available on the virtual platform for 3 months after the Congress dates.
We look forward to seeing you for the 16th Annual Congress of EAHAD, to be held from 8 to 10 February 2023, in Manchester, United Kingdom.
You can download the Press Release as a PDF here